Desmoteplase In Acute ischaemic Stroke "DIAS"

Completed

Phase N/A Results

Summary of Purpose

To assess the safety and thrombolytic efficacy of intravenous desmoteplase (vampire bat plasminogen activator) in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 January 2005.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Paion GmbH

Trial Design

Randomized, multi-center, multinational, double-blind, placebo-controlled, dose escalating trial.

Contacts

  • Dr Yasir Al-Rawi PAION GmbH Kaiserplatz 5 52222 Stolberg Germany

    clinical.development@paion.de